enGene Therapeuctics Inc Share Price Today: Live Updates & Key Insights
enGene Therapeuctics Inc share price today is $1.855, up -3.7%. The stock opened at $1.87 against the previous close of $1.89, with an intraday high of $1.87 and low of $1.81.
enGene Therapeuctics Inc Share Price Chart
enGene Therapeuctics Inc
enGene Therapeuctics Inc Share Price Performance
enGene Therapeuctics Inc Institutional Holdings
enGene Therapeuctics Inc Market Status
enGene Therapeuctics Inc Fundamentals
Market Cap 126.61 M
PB Ratio 0.487
PE Ratio 0.0
Enterprise Value -98.17 M
Total Assets 221.47 M
Volume 665841
enGene Therapeuctics Inc Company Financials
About enGene Therapeuctics Inc & investment objective
Company Information enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.
Organisation Biotechnology
Employees 81
Industry Biotechnology
CEO Mr. Ronald H. W. Cooper
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
enGene Therapeuctics Inc FAQs
What is the share price of enGene Therapeuctics Inc today?
The current share price of enGene Therapeuctics Inc is $1.855.
Can I buy enGene Therapeuctics Inc shares in India?
Yes, Indian investors can buy enGene Therapeuctics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy enGene Therapeuctics Inc shares in India?
You can easily invest in enGene Therapeuctics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy enGene Therapeuctics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of enGene Therapeuctics Inc.
Can I buy fractional shares of enGene Therapeuctics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of enGene Therapeuctics Inc?
enGene Therapeuctics Inc has a market cap of $126.61 M.
In which sector does enGene Therapeuctics Inc belong?
enGene Therapeuctics Inc operates in the Biotechnology sector.
What documents are required to invest in enGene Therapeuctics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of enGene Therapeuctics Inc?
The PE ratio of enGene Therapeuctics Inc is N/A and the PB ratio is 0.49.